Ex vivo-expanded bone marrow CD34+ for acute myocardial infarction treatment: In vitro and in vivo studies

Cytotherapy

Volumn 13, Issue 9, 2011, Pages 1140-1152

  Gunetti, Monica ^a   Noghero, Alessio ^b   Molla, Fabiola ^c   Staszewsky, Lidia Irene ^c   De Angelis, Noeleen ^c   Soldo, Annarita ^c   Russo, Ilaria ^c   Errichiello, Edoardo ^a   Frasson, Chiara ^d   Rustichelli, Deborah ^a   Ferrero, Ivana ^a,b   Gualandris, Anna ^b   Berger, Massimo ^a   Geuna, Massimo ^e   Scacciatella, Paolo ^f   Basso, Giuseppe ^d   Marra, Sebastiano ^f   Bussolino, Federico ^b   Latini, Roberto ^c   Fagioli, Franca ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e MAURIZIANO HOSPITAL   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

Author keywords

Cellular therapy; cytotherapy; stem cells; translational research

Indexed keywords

CD133 ANTIGEN; CD14 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; ENDOGLIN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CELL; CD34 SELECTION; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL SELECTION; CELL THERAPY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOKINE RELEASE; EX VIVO STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HEART FUNCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC TISSUE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

EID: 80052914670     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.597559     Document Type: Article

References (56)

1. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004;116:639-48. (Pubitemid 38326723)
2. Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res. 2005;96:151-63. (Pubitemid 40209362)
3. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-5. (Pubitemid 32290358)
4. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003;425:968-73. (Pubitemid 37376928)
5. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004;10:494-501. (Pubitemid 38667908)
6. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001;37:1726-32.
7. Galvez BG, Covarello D, Tolorenzi R, Brunelli S, Dellavalle A, Crippa S, et al. Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency. Cardiovasc Res. 2009;83:707-16.
8. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104:1046-52. (Pubitemid 32803883)
9. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94:678-85. (Pubitemid 38387752)
10. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-6. (Pubitemid 32298545)
11. Schuster MD, Kocher AA, Seki T, Martens TP, Xiang G, Homma S, et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol. 2004;287:H525-32. (Pubitemid 38955280)
12. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989-97. (Pubitemid 46835786)
13. Martin-Rendon E, Brunskill S, Doree C, Hyde C, Watt S, Mathur A, et al. Stem cell treatment for acute myocardial infarction. The Cochrane Practice Library 2009;3:1-116.
14. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29:1807-18.
15. Gammaitoni L, Bruno S, Sanavio F, Gunetti M, Kollet O, Cavalloni G, et al. Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol. 2003;31:261-70. (Pubitemid 36313269)
16. Gammaitoni L, Weisel KC, Gunetti M, Wu KD, Bruno S, Pinelli S, et al. Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. Blood. 2004;103:4440-8. (Pubitemid 38745969)
17. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, et al. Extensive amplifi cation and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89:2644-53. (Pubitemid 27172548)
18. Piacibello W, Sanavio F, Garetto L, Severino A, Dane A, Gammaitoni L, et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for selfrenewal and amplifi cation vs proliferation and differentiation. Leukemia. 1998;12:718-27. (Pubitemid 28220825)
19. Piacibello W, Sanavio F, Severino A, Dane A, Gammaitoni L, Fagioli F, et al. Engraftment in nonobese diabetic severe combined immunodefi cient mice of human CD34+ cord blood cells after ex vivo expansion: evidence for the amplifi cation and self-renewal of repopulating stem cells. Blood. 1999; 93:3736-49. (Pubitemid 29249820)
20. Droetto S, Viale A, Primo L, Jordaney N, Bruno S, Pagano M, et al. Vasculogenic potential of long term repopulating cord blood progenitors. FASEB J. 2004;18:1273-5. (Pubitemid 39561574)
21. Gunetti M, Ferrero I, Rustichelli D, Berger M, Gammaitoni L, Timeus F, et al. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian good manufacturing practice conditions. Exp Hematol. 2008;36:235-43.
22. Schroeder T, Meier-Stiegen F, Schwanbeck R, Eilken H, Nishikawa S, Hasler R, et al. Activated Notch1 alters differentiation of embryonic stem cells into mesodermal cell lineages at multiple stages of development. Mech Dev. 2006;123:570-9. (Pubitemid 44176343)
23. Galli D, Innocenzi A, Staszewsky L, Zanetta L, Sampaolesi M, Bai A, et al. Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fi broblasts, and endothelial cells. Arterioscler Thromb Vasc Biol. 2005;25:692-7. (Pubitemid 40463855)
24. Masson S, Arosio B, Luvara G, Gagliano N, Fiordaliso F, Santambrogio D, et al. Remodelling of cardiac extracellular matrix during beta-adrenergic stimulation: upregulation of SPARC in the myocardium of adult rats. J Mol Cell Cardiol. 1998;30:1505-14. (Pubitemid 28418641)
25. Becker M, Nitsche A, Neumann C, Aumann J, Junghahn I, Fichtner I. Sensitive PCR method for the detection and realtime quantifi cation of human cells in xenotransplantation systems. Br J Cancer. 2002;87:1328-35. (Pubitemid 36009141)
26. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: fi nal 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775-83. (Pubitemid 44871463)
27. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005; 111:2198-202. (Pubitemid 40632435)
28. Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006;113: 1311-25. (Pubitemid 43739453)
29. Campagnolo P, Cesselli D, Al Haj Zen A, Beltrami AP, Krankel N, Katare R, et al. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation. 2010;121:1735-45.
30. Ward MR, Stewart DJ, Kutryk MJ. Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv. 2007;70:983-98.
31. Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, Lee J, et al. CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res. 2010;107:602-14.
32. Gualandris A, Noghero A, Geuna M, Arese M, Valdembri D, Serini G, et al. Microenvironment drives the endothelial or neural fate of differentiating embryonic stem cells coexpressing neuropilin-1 and Flk-1. FASEB J. 2009;23:68-78.
33. Kuwana M, Okazaki Y, Kodama H, Satoh T, Kawakami Y, Ikeda Y. Endothelial differentiation potential of human monocytederived multipotential cells. Stem Cells. 2006;24:2733-43. (Pubitemid 46053011)
34. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F, et al. CD14+ CD34 low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. 2005;97:314-22. (Pubitemid 41216135)
35. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199-209. (Pubitemid 44427444)
36. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen monthsfollow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006;113:1287-94. (Pubitemid 43739450)
37. Boilson BA, Gulati R. Stem cell therapy for the heart: a perspective. Transl Res. 2010;155:3-5.
38. Das H, George JC, Joseph M, Das M, Abdulhameed N, Blitz A, et al. Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One. 2009;4:1-10.
39. Dimmeler S, Burchfi eld J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol. 2008;28:208-16. (Pubitemid 351161191)
40. Krenning G, van der Strate BW, Schipper M, van Seijen XJ, Fernandes BC, van Luyn MJ, et al. CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J Cell Mol Med. 2009;13:2521-33.
41. Balsam LB, Wagers AJ, Christensen JL, Kofi dis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428:668-73. (Pubitemid 38524811)
42. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664-8. (Pubitemid 38524810)
43. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, et al. Cardioprotective c-kit cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006;116:1865-77. (Pubitemid 44033311)
44. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell. 2009;4:313-23.
45. Lambert E, Dasse E, Haye B, Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004;49:187-98. (Pubitemid 38251351)
46. Li G, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res. 1999;59:6267-75. (Pubitemid 30035652)
47. Singla DK, McDonald DE. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol. 2007;293:H1590-5. (Pubitemid 47367204)
48. Frangogiannis NG. Chemokines in the ischemic myocardium: from infl ammation to fi brosis. Infl amm Res. 2004;53: 585-95.
49. Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, et al. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol. 2002;161:125-34. (Pubitemid 34760778)
50. Maier R, Weger M, Haller-Schober EM, El-Shabrawi Y, Wedrich A, Theisl A, et al. Multiplex bead analysis of vitreous and serum concentrations of infl ammatory and proangiogenic factors in diabetic patients. Mol Vis. 2008;14:637-43. (Pubitemid 351486723)
51. Waleh NS, Murphy BJ, Zaveri NT. Increase in tissue inhibitor of metalloproteinase-2 (TIMP-2) levels and inhibition of MMP-2 activity in a metastatic breast cancer cell line by an anti-invasive small molecule SR13179. Cancer Lett. 2010;289:111-8.
52. Zhang Y, Ingram DA, Murphy MP, Saadatzadeh MR, Mead LE, Prater DN, et al. Release of proinfl ammatory mediators and expression of proinfl ammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol. 2009;296:H1675-82.
53. Azevedo LC, Pedro MA, Laurindo FR. Circulating microparticles as therapeutic targets in cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2007;2:41-51. (Pubitemid 46813415)
54. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007;110: 2440-8. (Pubitemid 47523165)
55. Quesenberry PJ, Dooner MS, Aliotta JM. Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles. Exp Hematol. 2010;38:581-92.
56. E uropean Parliament and Council. Regulation (EC) N. 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products. Brussels: European Parliament and Council; Offi cial Journal of the European Union, Brussels, 2007.